To Give Birth or Not to Give Birth
By Evelina Johansson Wilén,
Jacobin
| 01. 18. 2026
In her book The Argonauts, Maggie Nelson describes pregnancy as an experience marked by a peculiar duality. On the one hand, it is deeply transformative, bodily alien, sometimes almost incomprehensible to the person undergoing it. On the other hand, pregnancy is one of the most socially accepted — nearly invisible — states one can inhabit. The same paradox applies to parenthood. At a societal level, it appears as an almost self-evident life choice: something statistically expected of most people and silently assumed as a precondition for the survival of the state and the welfare system. Yet for the individual, the decision to become a parent is rarely self-evident. On the contrary, it is often one of the most far-reaching and irreversible decisions a person can make, saturated with hope, anticipation, fear, and anxiety. Having children is simultaneously norm and exception, routine and existential leap.
In a time marked by economic and political uncertainty, fewer and fewer people are taking that leap. Birth rates are falling, and what long appeared stable now looks fragile. In 2024, the Swedish government appointed...
Related Articles
By Alondra Nelson, Science | 01.15.2026
One of the most interventionist approaches to technology governance in the United States in a generation has cloaked itself in the language of deregulation. In early December 2025, President Donald Trump took to Truth Social to announce a forthcoming “One...
By Daphne O. Martschenko and Julia E. H. Brown, Hastings Bioethics Forum | 01.14.2026
There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement known as pronatalism looks to combat depopulation by encouraging people to have as many children as possible. But not just...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By Nick Paul Taylor, Fierce Biotech | 01.09.2026
Menlo Ventures has made a $16 million bet that the “baby KJ” custom CRISPR therapy success story is repeatable. The funding has enabled CRISPR co-inventor Jennifer Doudna, Ph.D., and baby KJ scientist Fyodor Urnov, Ph.D., to launch Aurora...